000			02165 a2200601 4500
005			20250514005552.0
264		0	_c20010913
008			200109s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/hc3301.094533 _2doi
040			_aNLM _beng _cNLM
100	1		_aTcheng, J E
245	0	0	_aAbciximab readministration: results of the ReoPro Readministration Registry. _h[electronic resource]
260			_bCirculation _cAug 2001
300			_a870-5 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAbciximab
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aAntibodies _xblood
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAspirin _xadministration & dosage
650	0	4	_aCoronary Disease _xblood
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Administration Schedule
650	0	4	_aHemorrhage _xetiology
650	0	4	_aHeparin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xadministration & dosage
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPostoperative Complications _xprevention & control
650	0	4	_aRegistries _xstatistics & numerical data
650	0	4	_aThrombocytopenia _xdiagnosis
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aVascular Patency _xdrug effects
700	1		_aKereiakes, D J
700	1		_aLincoff, A M
700	1		_aGeorge, B S
700	1		_aKleiman, N S
700	1		_aSane, D C
700	1		_aCines, D B
700	1		_aJordan, R E
700	1		_aMascelli, M A
700	1		_aLangrall, M A
700	1		_aDamaraju, L
700	1		_aSchantz, A
700	1		_aEffron, M B
700	1		_aBraden, G A
773	0		_tCirculation _gvol. 104 _gno. 8 _gp. 870-5
856	4	0	_uhttps://doi.org/10.1161/hc3301.094533 _zAvailable from publisher's website
999			_c11438937 _d11438937